Doximity, Inc.
DOCS · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $11 | $5 | $6 | $9 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $11 | $5 | $6 | $8 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 20% | 13.5% | 22% | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 90.2% | 89.3% | 87.2% | 88.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 42.2% | 38.3% | 32.3% | 34.5% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 39.1% | 31% | 26.9% | 45.1% |
| EPS Diluted | 1.11 | 0.72 | 0.53 | 0.7 |
| % Growth | 54.2% | 35.8% | -24.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |